Exlservice Holdings, Inc. quarterly report, Q1 FY2023

ExlService Holdings, Inc. — Q1 2023 Form 10-Q

Reporting period: Three months ended March 31, 2023; unaudited consolidated results. ExlService provides data analytics and digital operations and solutions, with Insurance, Healthcare, Emerging Business and Analytics reportable segments.

Financial performance

MetricQ1 2023Q1 2022 / comparison
Revenue$400.6 million$329.2 million; up 21.7%
Gross profit / margin$149.2 million / 37.2%$121.7 million / 37.0%
Operating income / margin$59.4 million / 14.8%$44.0 million / 13.4%
Net income / margin$51.3 million / 12.8%$36.2 million / 11.0%
Diluted EPS$1.51$1.07
Operating cash flow$16.0 million$(26.9) million

Revenue growth was led by Analytics (+22.0%), Emerging Business (+30.4%) and Insurance (+22.0%); Healthcare grew 2.1%. Analytics was the largest segment at $181.8 million, or 45.4% of revenue. Overall gross margin increased 20 basis points, but Insurance and Healthcare margins declined 240 and 290 basis points, respectively; Analytics and Emerging Business margins improved.

Cash, cash equivalents and short-term investments totaled $203.8 million at March 31, 2023. Borrowings were $200.0 million, down from $250.0 million at December 31, 2022. The company had a $400 million revolving facility maturing April 2027 and reported compliance with its covenants. The effective borrowing rate was 5.9%, versus 1.3% a year earlier. Q1 capital expenditures were $12.5 million. The company repurchased $35.8 million of shares under its repurchase program.

Changes, outlook and risks

  • Management attributed growth mainly to higher volumes and expansion with new and existing clients. Higher employee costs, headcount and wage inflation contributed to rising delivery costs; SG&A increased 18.9%.
  • Net income benefited from lower income tax expense ($8.1 million versus $11.2 million), including higher excess tax benefits from stock-based compensation. The effective tax rate fell to 13.6% from 23.7%. Higher interest expense and lower foreign-exchange gains partly offset operating growth.
  • Management expects 2023 capital expenditures of $47–$52 million and states existing liquidity and sources of liquidity should cover cash requirements for the next 12 months. It anticipates primarily funding needs from operating cash flow; significant acquisition-led growth could require additional financing. No full-year revenue or earnings guidance is provided in the filing text.
  • Key business risks include client demand and contract termination, concentration, long sales cycles, wage inflation and talent retention, pricing and multi-vendor competition, foreign-exchange exposure, cybersecurity, and execution of growth and technology initiatives. The top ten clients generated 34.8% of Q1 revenue.
  • Indian tax disputes include transfer-pricing demands of $37.1 million net of advance payments and VAT demands of $5.6 million, plus rejected GST refund claims of $3.9 million. The company has not accrued liabilities for these matters, stating it believes its positions will be sustained. Pending litigation loss ranges, if any, could not be reasonably estimated; management does not expect a material adverse effect.
  • Operating cash flow turned positive year over year, but receivables increased and cash flow benefited from working-capital movements. Investing cash inflow included substantial net redemptions of investments; financing outflow reflected debt repayments and share repurchases. Management also notes uninsured bank-deposit exposure, while stating deposits are diversified and it has not experienced losses.

Important facts for investors to verify

  • Whether revenue growth and improved consolidated margins continue, particularly given weaker Healthcare growth and lower Insurance and Healthcare margins.
  • Cash conversion, receivables and unbilled receivables (accounts receivable included $156.0 million unbilled at quarter-end), alongside planned capital spending and repurchases.
  • Interest-rate and foreign-exchange exposure, debt repayments, and continued compliance with credit-facility covenants.
  • Developments in Indian tax disputes and other contingencies, and any resulting cash deposits, liabilities or financial-statement impacts.
  • The sustainability of the unusually low Q1 effective tax rate, which was influenced by stock-based compensation tax benefits.